Ghost Tree Capital as of March 31, 2019
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 38 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 17.5 | $67M | 570k | 117.70 | |
| ACADIA Pharmaceuticals (ACAD) | 6.3 | $24M | 900k | 26.85 | |
| Blueprint Medicines (BPMC) | 5.0 | $19M | 240k | 80.05 | |
| Amicus Therapeutics (FOLD) | 4.6 | $18M | 1.3M | 13.60 | |
| Global Blood Therapeutics In | 4.2 | $16M | 300k | 52.93 | |
| Immunomedics | 4.0 | $15M | 800k | 19.21 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.8 | $15M | 80k | 183.95 | |
| Alnylam Pharmaceuticals (ALNY) | 3.7 | $14M | 150k | 93.45 | |
| Sage Therapeutics (SAGE) | 3.1 | $12M | 75k | 159.05 | |
| Kalvista Pharmaceuticals (KALV) | 3.0 | $11M | 400k | 28.62 | |
| Retrophin | 3.0 | $11M | 500k | 22.63 | |
| Mirati Therapeutics | 2.9 | $11M | 150k | 73.30 | |
| Iovance Biotherapeutics (IOVA) | 2.9 | $11M | 1.2M | 9.51 | |
| Rocket Pharmaceuticals (RCKT) | 2.8 | $11M | 600k | 17.54 | |
| Cymabay Therapeutics | 2.6 | $10M | 750k | 13.28 | |
| Biohaven Pharmaceutical Holding | 2.4 | $9.0M | 175k | 51.47 | |
| Protagonist Therapeutics (PTGX) | 2.3 | $8.8M | 700k | 12.57 | |
| Invesco exchange traded (FXF) | 2.2 | $8.6M | 92k | 93.40 | |
| Anaptysbio Inc Common (ANAB) | 2.2 | $8.4M | 115k | 73.05 | |
| Momenta Pharmaceuticals | 1.9 | $7.3M | 500k | 14.53 | |
| Audentes Therapeutics | 1.8 | $6.8M | 175k | 39.02 | |
| Ra Pharmaceuticals | 1.8 | $6.7M | 300k | 22.40 | |
| Dbv Technologies S A (DBVT) | 1.7 | $6.6M | 850k | 7.71 | |
| Epizyme | 1.6 | $6.2M | 500k | 12.39 | |
| Coherus Biosciences (CHRS) | 1.6 | $6.1M | 450k | 13.64 | |
| Tricida | 1.5 | $5.8M | 150k | 38.62 | |
| Viewray (VRAYQ) | 1.4 | $5.5M | 750k | 7.39 | |
| Kadmon Hldgs | 1.4 | $5.5M | 2.1M | 2.64 | |
| Orchard Therapeutics Plc ads | 1.4 | $5.4M | 300k | 17.88 | |
| Axsome Therapeutics (AXSM) | 1.1 | $4.4M | 310k | 14.23 | |
| BioCryst Pharmaceuticals (BCRX) | 1.1 | $4.1M | 500k | 8.14 | |
| Chiasma | 0.9 | $3.6M | 700k | 5.20 | |
| Obseva Sa | 0.7 | $2.6M | 200k | 12.79 | |
| Arvinas Ord (ARVN) | 0.7 | $2.6M | 175k | 14.76 | |
| Genocea Biosciences | 0.3 | $1.2M | 2.0M | 0.59 | |
| Solid Biosciences | 0.2 | $920k | 100k | 9.20 | |
| Catalyst Biosciences | 0.2 | $811k | 100k | 8.11 | |
| Fibrogen (FGEN) | 0.2 | $625k | 12k | 54.35 |
